Zhenhua Wu, Ph.D.
Chief Executive Officer

Dr. Zhenhua Wu is the Founder, Chairman and Chief Executive Officer of Exegenesis Bio. Dr. Wu is a senior discovery and development leader with more than 20 years’ experience and a deep understanding of pharmaceutical R&D value chain. He has extensive R&D experience in small molecule, vaccine and cell and gene therapy.Dr. Wu was the CEO of NeuExcell Therapeutics, overseeing all corporate operations and business activities. Previously he was the Vice President, Head of Preclinical Development at United Neuroscience, and oversaw the strategy and execution of preclinical research and development. He served as a director of neuroscience therapeutic area at GlaxoSmithKline, where he led cell and gene therapy and small molecule projects for the treatment of neurodegenerative and neuroinflammatory diseases. He had worked in various functional areas in Merck & Co. for ten years where he led various neuroscience projects. Dr. Wu received his Ph.D. degree in neuroscience from University of Rochester.

Scroll to top